EyePoint Pharmaceuticals, Inc.EYPTNASDAQ
Loading
Current Ratio Over TimeElevated
Percentile Rank79
3Y CAGR+21.1%
5Y CAGR+15.9%
Year-over-Year Change
Current ratio (current assets / current liabilities)
3Y CAGR
+21.1%/yr
vs +28.4%/yr prior
5Y CAGR
+15.9%/yr
Recent acceleration
Acceleration
-7.3pp
Decelerating
Percentile
P79
Within normal range
vs 5Y Ago
2.1x
Strong expansion
Streak
3 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 8.88 | +13.6% |
| 2024 | 7.81 | +43.4% |
| 2023 | 5.45 | +8.9% |
| 2022 | 5.00 | -50.2% |
| 2021 | 10.05 | +137.0% |
| 2020 | 4.24 | +17.1% |
| 2019 | 3.62 | +96.6% |
| 2018 | 1.84 | -45.1% |
| 2017 | 3.35 | -43.0% |
| 2016 | 5.88 | - |